Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.

Healthcare distributor and services company Cardinal Health (NYSE:CAH) will be announcing earnings results this Tuesday ...

Key Insights Institutions' substantial holdings in Cardinal Health implies that they have significant influence ...

Analysts expect the health care company to report quarterly earnings at $2.03 per share, up from $1.84 per share in the ...

Cardinal Health, Inc. (NYSE:CAH) will release earnings results for the fourth quarter before the opening bell on Tuesday, Aug ...

Approximately six in 10 U.S. adults reported taking a prescription drug, and a quarter of U.S. adults take four or more.

U.S. stock futures are down, with earnings from Cardinal Health Inc. and Sea Ltd. to watch. ZipRecruiter Inc. beats ...

Schuyler County will receive up to $38,000 from a settlement with drug company Sandoz, Inc. and its affiliates over claims tied to the opioid crisis. The county legislature approved the settlement ...

Blackstone, Cinven, Thoma Bravo, TPG and Silver Lake were among the PE firms completing deals that stood out. While many ...

As companies expand their tech stacks and accelerate digital operations, they may be ignoring risks rooted in shadow systems, ...

119 JCPenney stores sold in nearly $1 billion deal. See list of locations.

Cardinal Health’s CEO says “ruthless prioritization” was needed to turn around the Fortune 500 company whose earnings plummeted $300 million just three years ago.